Loading company…
System1 Biosciences, based in San Francisco, applies advanced technology to drug discovery and development.
Founded in 2017 in San Francisco, US, System1 Biosciences, Inc. focuses on drug discovery, offering high-throughput screening and data analytics services to biotech and pharmaceutical companies. Its services are sold per project. Co-founded by Saul Kato and Sean Escola, the company raised USD 25.00 mn in a Series A round on August 2, 2018, with investors including CRV and Pfizer Venture Investments.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in